Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double Blind, Placebo Controlled RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19

NCT04667247 is registered in ClinicalTrials.gov with Gordon Saxe as lead sponsor.

NCT NCT04667247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04667247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double Blind, Placebo Controlled RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19
Lead sponsor
Gordon Saxe
Phase
Phase 1/2
Overall status
Completed
Start date
December 23, 2020
Completion date
May 4, 2022
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19